פרוטוקולים אונקולוגיה

EsPhALL: Amendment proposal

25 במרץ 2010 14:08 אין תגובות

An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+

קרא עוד ←

Neuroblastoma

9 בדצמבר 2009 16:09 אין תגובות

Natia Esiashvili MD, Cynthia Anderson MD, Howard M.Katzenstein MD
Current Problems in Cancer
Volume 33, Issue 6, November–December 2009, Pages 333-360

קרא עוד ←

EsPhALL: EUDRACT-n° 2004-001647-30

1 בדצמבר 2009 14:14 אין תגובות

An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+

קרא עוד ←

Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

AEWS07P1 – A Pilot Study of Chemotherapy Intensification by Adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents with an Interval Compression Schedule in Newly Diagnosed Patients with Localized Ewing Sarcoma Family of Tumors

Recent Advances in Neuroblastoma

AGCT0132 | A PHASE III STUDY OF REDUCED THERAPY IN THE TREATMENT OF CHILDREN WITH LOW AND INTERMEDIATE RISK EXTRACRANIAL GERM CELL TUMORS

EsPhALL: Amendment proposal

Neuroblastoma

EsPhALL: EUDRACT-n° 2004-001647-30

NRSTS 2005 – a protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas

האיגוד הישראלי להמטולוגיה ולאונקולוגיה ילדים